Author: edra

Original Article

Sensitisation to Lep d 2- Lepidoglyphus destructor allergy in asthma and rhinitis

by edra

Background. Mites are responsible for allergic diseases, such as asthma and rhinitis, in nearly 1.5% of the world population. It is known that nowadays, besides House Dust Mites (HDM), Storage Mites (SM) are important sensitisers in urban non-occupational dwellings, predominantly in the Mediterranean area. The main objective of our study was to analyse the clinical […]

Read more »

Letter to the Editor

Peanut allergen sensitization profile in Brazil

/ by edra

Read more »

Original Article

Allergic rhinitis management: a survey on Italian primary care pediatricians

/ by edra

Background. Allergic rhinitis (AR) is a widespread condition. The Italian Society of Pediatric Allergology and Immunology (SIAIP) promoted an initiative to update the knowledge on AR in children and adolescents. The present survey directly addressed primary care pediatricians, thus reflecting the real-world management of AR in children and adolescents. The aim was to investigate common […]

Read more »

Letter to the Editor

The future of telemedicine after COVID-19 pandemic

/ by edra

Read more »

Original Article

Sleep and quality of life in adults with atopic dermatitis: cross sectional study

/ by edra

Background. Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease that causes sleep disturbances and worsens quality of life. However, few studies have been conducted on sleep in adults with atopic dermatitis. This study aimed to evaluate sleep and quality of life in adults with AD. Methods. A cross-sectional study was conducted with 36 adults […]

Read more »

Letter to the Editor

Baricitinib for atopic dermatitis in real life: effectiveness, safety profile, and adherence

/ by edra

Read more »

Letter to the Editor

Stress in Brazilian patients with inborn errors of immunity during the SARS-CoV-2 pandemic

/ by edra

Read more »

Letter to the Editor

Severe CSU with low total IgE levels: is the response to omalizumab always delayed or absent?

/ by edra

Read more »

Original Article

Venom immunotherapy in clinical practice: comparison of two ultra-rush protocols

/ by edra

Background. Ultra-rush venom immunotherapy protocols have shown to be a safe and effective approach to prevent the occurrence of systemic reactions after hymenoptera stings. The aim was to describe our experience with two ultra-rush protocols – a five-step with 1 µg starting dose and a six-step with 0.1 µg starting dose, as well as to […]

Read more »

Original Article

Allergen immunotherapy effectiveness in specific nasal reactivity of children with local allergic rhinitis

/ by edra

Background. Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. Its efficacy has been demonstrated in the treatment of Local Allergic Rhinitis (LAR) in adults. This study intends to evaluate the effectiveness of AIT in specific nasal reactivity of paediatric patients with LAR. Methods. Patients diagnosed with LAR to Dermatophagoides pteronyssinus (Dp) were submitted to subcutaneous […]

Read more »

To top